From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging (325 views)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2012 Sep; 158(3): 415-418.
Export to BibTeX Export to EndNote
Paper type: Letter, Research Support, Non-U. S. Gov'T,
Impact factor: 4.942, 5-year impact factor: 4.726
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84863857069&partnerID=40&md5=081c04aaa783e08e73b6dfc7d4670397
Keywords: Eculizumab, Iron Metabolism, Iron Overload, Paroxysmal Nocturnal Haemoglobinuria, Complement Component C3, Ferritin, Hemosiderin, Abnormal Urine Composition, Adolescent, Adult, Clinical Article, Drug Response, Female, Ferritin Blood Level, Hemosiderinuria, Human, Hyperferritinemia, Kidney, Kidney Hemosiderosis, Letter, Liver, Liver Hemosiderosis, Nuclear Magnetic Resonance Imaging, Paroxysmal Nocturnal Hemoglobinuria, Priority Journal, Side Effect, Spleen, Antibodies, Monoclonal, Humanized, Middle Aged, Treatment Outcome, Young Adult, Humanized Therapeutic Use, Paroxysmal Blood Drug Therapy Immunology, Hemosiderin Urine, Iron Overload Blood, Magnetic Resonance Imaging Methods,
Affiliations:
*** IBB - CNR ***
Division of Haematology, Department of Biochemistry and Medical Biotechnologies, Federico II University, Naples, Italy
Department of Radiology, Federico II University, Naples, Italy
Department of Haematology, University of Pavia Medical School, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
Department of Cellular Biotechnologies and Haematology, Università La Sapienza, Rome, Italy
Core Research Laboratory, Istituto Toscano Tumori, Florence, Italy
Department of Internal Medicine, Federico II University, Naples, Italy
References:
Deugnier, Y., Turlin, B., Pathology of hepatic iron overload (2007) World Journal of Gastroenterology, 13, pp. 4755-476
Gandon, Y., Guyader, D., Heautot, J.F., Reda, M.I., Yaouanq, J., Buhé, T., Brissot, P., Deugnier, Y., Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging (1994) Radiology, 193, pp. 533-538
Hillmen, P., Young, N.S., Schubert, J., Brodsky, R.A., Socié, G., Muus, P., Röth, A., Luzzatto, L., The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria (2006) New England Journal of Medicine, 355, pp. 1233-1243
Kelly, R.J., Hill, A., Arnold, L.M., Brooksbank, G.L., Richards, S.J., Cullen, M., Mitchell, L.D., Hillmen, P., Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival (2011) Blood, 117, pp. 6786-6792
Mathieu, D., Rahmouni, A., Villeneuve, P., Anglade, M.C., Rochant, H., Vasile, N., Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria (1995) Blood, 85, pp. 3283-3288
Parker, C., Omine, M., Richards, S., Nishimura, J., Bessler, M., Ware, R., Hillmen, P., Socié, G., Diagnosis and management of paroxysmal nocturnal hemoglobinuria (2005) Blood, 106, pp. 3699-3709. , International PNH Interest Group
Risitano, A.M., Notaro, R., Marando, L., Serio, B., Ranaldi, D., Seneca, E., Ricci, P., Rotoli, B., Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab (2009) Blood, 113, pp. 4094-4100
Risitano, A.M., Seneca, E., Marando, L., Imbraco, M., Soscia, E., Soscia, F., Micol Pizzuti, L., Rotoli, B., From renal siderosis due to perpetual hemosiderinuria to possible liver overload due to extravascular hemolysis: changes in iron metabolism in paroxysmal nocturnal hemoglobinuria (PNH) patients on eculizumab (2009) Blood, 114, p. 4031. , abs)
Risitano, A.M., Perna, F., Selleri, C., Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3 (2011) Mini Reviews in Medicinal Chemistry, 11, pp. 528-535
Röth, A., Hock, C., Konik, A., Christoph, S., Dührsen, U., Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena (2011) International Journal of Hematology, 93, pp. 704-714
Kelly, R. J., Hill, A., Arnold, L. M., Brooksbank, G. L., Richards, S. J., Cullen, M., Mitchell, L. D., Hillmen, P., Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival (2011) Blood, 117, pp. 6786-6792
Risitano, A. M., Notaro, R., Marando, L., Serio, B., Ranaldi, D., Seneca, E., Ricci, P., Rotoli, B., Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab (2009) Blood, 113, pp. 4094-4100
Risitano, A. M., Seneca, E., Marando, L., Imbraco, M., Soscia, E., Soscia, F., Micol Pizzuti, L., Rotoli, B., From renal siderosis due to perpetual hemosiderinuria to possible liver overload due to extravascular hemolysis: changes in iron metabolism in paroxysmal nocturnal hemoglobinuria (PNH) patients on eculizumab (2009) Blood, 114, p. 4031. , abs)
Risitano, A. M., Perna, F., Selleri, C., Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3 (2011) Mini Reviews in Medicinal Chemistry, 11, pp. 528-535
R th, A., Hock, C., Konik, A., Christoph, S., D hrsen, U., Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena (2011) International Journal of Hematology, 93, pp. 704-714
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2012 Sep; 158(3): 415-418.
Export to BibTeX Export to EndNote
Paper type: Letter, Research Support, Non-U. S. Gov'T,
Impact factor: 4.942, 5-year impact factor: 4.726
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84863857069&partnerID=40&md5=081c04aaa783e08e73b6dfc7d4670397
Keywords: Eculizumab, Iron Metabolism, Iron Overload, Paroxysmal Nocturnal Haemoglobinuria, Complement Component C3, Ferritin, Hemosiderin, Abnormal Urine Composition, Adolescent, Adult, Clinical Article, Drug Response, Female, Ferritin Blood Level, Hemosiderinuria, Human, Hyperferritinemia, Kidney, Kidney Hemosiderosis, Letter, Liver, Liver Hemosiderosis, Nuclear Magnetic Resonance Imaging, Paroxysmal Nocturnal Hemoglobinuria, Priority Journal, Side Effect, Spleen, Antibodies, Monoclonal, Humanized, Middle Aged, Treatment Outcome, Young Adult, Humanized Therapeutic Use, Paroxysmal Blood Drug Therapy Immunology, Hemosiderin Urine, Iron Overload Blood, Magnetic Resonance Imaging Methods,
Affiliations:
*** IBB - CNR ***
Division of Haematology, Department of Biochemistry and Medical Biotechnologies, Federico II University, Naples, Italy
Department of Radiology, Federico II University, Naples, Italy
Department of Haematology, University of Pavia Medical School, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
Department of Cellular Biotechnologies and Haematology, Università La Sapienza, Rome, Italy
Core Research Laboratory, Istituto Toscano Tumori, Florence, Italy
Department of Internal Medicine, Federico II University, Naples, Italy
References:
Deugnier, Y., Turlin, B., Pathology of hepatic iron overload (2007) World Journal of Gastroenterology, 13, pp. 4755-476
Gandon, Y., Guyader, D., Heautot, J.F., Reda, M.I., Yaouanq, J., Buhé, T., Brissot, P., Deugnier, Y., Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging (1994) Radiology, 193, pp. 533-538
Hillmen, P., Young, N.S., Schubert, J., Brodsky, R.A., Socié, G., Muus, P., Röth, A., Luzzatto, L., The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria (2006) New England Journal of Medicine, 355, pp. 1233-1243
Kelly, R.J., Hill, A., Arnold, L.M., Brooksbank, G.L., Richards, S.J., Cullen, M., Mitchell, L.D., Hillmen, P., Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival (2011) Blood, 117, pp. 6786-6792
Mathieu, D., Rahmouni, A., Villeneuve, P., Anglade, M.C., Rochant, H., Vasile, N., Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria (1995) Blood, 85, pp. 3283-3288
Parker, C., Omine, M., Richards, S., Nishimura, J., Bessler, M., Ware, R., Hillmen, P., Socié, G., Diagnosis and management of paroxysmal nocturnal hemoglobinuria (2005) Blood, 106, pp. 3699-3709. , International PNH Interest Group
Risitano, A.M., Notaro, R., Marando, L., Serio, B., Ranaldi, D., Seneca, E., Ricci, P., Rotoli, B., Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab (2009) Blood, 113, pp. 4094-4100
Risitano, A.M., Seneca, E., Marando, L., Imbraco, M., Soscia, E., Soscia, F., Micol Pizzuti, L., Rotoli, B., From renal siderosis due to perpetual hemosiderinuria to possible liver overload due to extravascular hemolysis: changes in iron metabolism in paroxysmal nocturnal hemoglobinuria (PNH) patients on eculizumab (2009) Blood, 114, p. 4031. , abs)
Risitano, A.M., Perna, F., Selleri, C., Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3 (2011) Mini Reviews in Medicinal Chemistry, 11, pp. 528-535
Röth, A., Hock, C., Konik, A., Christoph, S., Dührsen, U., Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena (2011) International Journal of Hematology, 93, pp. 704-714
Kelly, R. J., Hill, A., Arnold, L. M., Brooksbank, G. L., Richards, S. J., Cullen, M., Mitchell, L. D., Hillmen, P., Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival (2011) Blood, 117, pp. 6786-6792
Risitano, A. M., Notaro, R., Marando, L., Serio, B., Ranaldi, D., Seneca, E., Ricci, P., Rotoli, B., Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab (2009) Blood, 113, pp. 4094-4100
Risitano, A. M., Seneca, E., Marando, L., Imbraco, M., Soscia, E., Soscia, F., Micol Pizzuti, L., Rotoli, B., From renal siderosis due to perpetual hemosiderinuria to possible liver overload due to extravascular hemolysis: changes in iron metabolism in paroxysmal nocturnal hemoglobinuria (PNH) patients on eculizumab (2009) Blood, 114, p. 4031. , abs)
Risitano, A. M., Perna, F., Selleri, C., Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3 (2011) Mini Reviews in Medicinal Chemistry, 11, pp. 528-535
R th, A., Hock, C., Konik, A., Christoph, S., D hrsen, U., Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena (2011) International Journal of Hematology, 93, pp. 704-714
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging
Not available.
Not available.
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging
No results. |
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging
Other filter: ([btitle,keywords] "Eculizumab" OR [btit ...
Petrillo S, Manco M, Altruda F, Fagoonee S, Tolosano E
* Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis (15 views)
Antioxid Redox Signal (ISSN: 1523-0864linking, 1557-7716), 2021 Aug 20; 35(6): 474-486.
Impact Factor: 7.04
View Export to BibTeX Export to EndNote
Dubbioso R, Ruggiero L, Esposito M, Tarantino P, De Angelis M, Aruta F, Pappata S, Ugga L, Piperno A, Iorio R, Santoro L, Iodice R, Manganelli F
* Different cortical excitability profiles in hereditary brain iron and copper accumulation (121 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2020 Mar; 41(3): 679-685.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Balasco N, Vitagliano L, Merlino A, Verde C, Mazzarella L, Vergara A
* The unique structural features of carbonmonoxy hemoglobin from the sub-Antarctic fish Eleginops maclovinus (149 views)
Sci Rep (ISSN: 2045-2322linking, 2045-2322electronic), 2019 Dec 12; 9(1): 18987-18987.
Impact Factor: 5.078
View Export to BibTeX Export to EndNote
Risitano AM, Seneca E, Marando L, Imbriaco M, Soscia E, Soscia F, Pizzuti LM, Malcovati L, Fenu S, Iori AP, Notaro R, Matarazzo M, Rotoli B
* From Renal Siderosis Due to Perpetual Hemosiderinuria to Possible Liver Overload Due to Extravascular Hemolysis: Changes in Iron Metabolism in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients On Eculizumab (322 views)
Haematologica (ISSN: 0006-4971, 0006-6497, 0390-6078), 2009 Nov 20; 114(22): N/D-N/D.
Impact Factor: 10.555
View Export to BibTeX Export to EndNote
* Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis (15 views)
Antioxid Redox Signal (ISSN: 1523-0864linking, 1557-7716), 2021 Aug 20; 35(6): 474-486.
Impact Factor: 7.04
View Export to BibTeX Export to EndNote
Dubbioso R, Ruggiero L, Esposito M, Tarantino P, De Angelis M, Aruta F, Pappata S, Ugga L, Piperno A, Iorio R, Santoro L, Iodice R, Manganelli F
* Different cortical excitability profiles in hereditary brain iron and copper accumulation (121 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2020 Mar; 41(3): 679-685.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Balasco N, Vitagliano L, Merlino A, Verde C, Mazzarella L, Vergara A
* The unique structural features of carbonmonoxy hemoglobin from the sub-Antarctic fish Eleginops maclovinus (149 views)
Sci Rep (ISSN: 2045-2322linking, 2045-2322electronic), 2019 Dec 12; 9(1): 18987-18987.
Impact Factor: 5.078
View Export to BibTeX Export to EndNote
Risitano AM, Seneca E, Marando L, Imbriaco M, Soscia E, Soscia F, Pizzuti LM, Malcovati L, Fenu S, Iori AP, Notaro R, Matarazzo M, Rotoli B
* From Renal Siderosis Due to Perpetual Hemosiderinuria to Possible Liver Overload Due to Extravascular Hemolysis: Changes in Iron Metabolism in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients On Eculizumab (322 views)
Haematologica (ISSN: 0006-4971, 0006-6497, 0390-6078), 2009 Nov 20; 114(22): N/D-N/D.
Impact Factor: 10.555
View Export to BibTeX Export to EndNote
4 Records (3 excluding Abstracts).
Total impact factor: 23.988 (13.433 excluding Abstracts).
Total 5 year impact factor: 23.104 (13.204 excluding Abstracts).
Total impact factor: 23.988 (13.433 excluding Abstracts).
Total 5 year impact factor: 23.104 (13.204 excluding Abstracts).
325 views. Last view on Tuesday 20 September 2022, 20:36:17
ibb.cnr.it